gal021 and Pituitary-Neoplasms

gal021 has been researched along with Pituitary-Neoplasms* in 1 studies

1 other study(ies) available for gal021 and Pituitary-Neoplasms

Article	Year
High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK Biomolecules, 2020, 01-25, Volume: 10, Issue:2 Topics: Calcium; Diazoxide; HEK293 Cells; Humans; Ionomycin; Pituitary Neoplasms; Respiration; Triazines; Verteporfin	2020